B
BOTH
vs
ARCC
ARCC
Over the past 12 months, BOTH has underperformed ARCC, delivering a return of -99% compared to the ARCC's 11% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
ARCC
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
B
|
Bioethics Ltd
OTC:BOTH
|
0.0051
USD
|
|||||
|
Ares Capital Corp
NASDAQ:ARCC
|
20.78
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
BOTH, ARCC
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
B
|
Bioethics Ltd
Revenue
|
|||||||||||
|
Ares Capital Corp
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
BOTH, ARCC
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
B
|
Bioethics Ltd
OTC:BOTH
|
|||||||||
|
Ares Capital Corp
NASDAQ:ARCC
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
BOTH, ARCC
Performance Gap
BOTH, ARCC
Performance By Year
BOTH, ARCC
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.